HSCS·July 23, 2026·going-concern
HeartSciences Flags Going Concern Doubt as It Seeks FDA Clearance and Platform Adoption
HeartSciences Inc. reported in its annual filing that its independent auditor has expressed substantial doubt about the company's ability to continue as a going concern, citing recurring losses and the need for additional funding to support operations, regulatory clearance, and commercialization.